![Olivier Jarry](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Olivier Jarry
Director/Board Member at
OS THERAPIES INCORPORATED
Profile
Olivier R.
Jarry is the founder of Libera Bio SL, founded in 2018, serving as Chief Executive Officer.
Current jobs include Independent Non-Executive Director at OS Therapies, Inc. since 2024, Chief Financial Officer at Rational Vaccines, Inc. since 2021, and Chief Operating Officer at ADvantage Therapeutics, Inc. since 2023.
Former jobs include Senior VP-Strategy & Business Development at DarioHealth Corp.
from 2017 to 2020, Head-Strategy, Operations & Market Access at Bristol Myers Squibb Co. from 2011 to 2012, Head-Strategy, Business Development & Licensing at Novartis International AG, Senior Vice President-Consumer Sector at Precigen, Inc. from 2015 to 2016, and Head-Bayer Diabetes Care at Bayer Healthcare Pharmaceuticals LLC from 2009 to 2010.
Education includes graduate studies at École Centrale Paris and an MBA from Trium Global Emba.
Olivier Jarry active positions
| Companies | Position | Start |
|---|---|---|
| OS THERAPIES INCORPORATED | Director/Board Member | 2024-10-27 |
Advantage Therapeutics, Inc.
 Advantage Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops immunotherapies treat neurodegenerative conditions | Chief Operating Officer | 2023-04-30 |
Rational Vaccines, Inc.
 Rational Vaccines, Inc. BiotechnologyHealth Technology Develops virus vaccines for retraining the immune systems | Director of Finance/CFO | 2021-07-31 |
Libera Bio SL
 Libera Bio SL Miscellaneous Commercial ServicesCommercial Services Operates as biopharmaceutical company that develops cancer therapeutics | Chief Executive Officer | 2018-03-31 |
Former positions of Olivier Jarry
| Companies | Position | End |
|---|---|---|
| DARIOHEALTH CORP. | President | 2020-01-12 |
| PRECIGEN, INC. | Corporate Officer/Principal | 2015-12-31 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 2011-12-31 |
Bayer Healthcare Pharmaceuticals LLC | Corporate Officer/Principal | 2009-12-31 |
Novartis International AG
 Novartis International AG Pharmaceuticals: MajorHealth Technology Offers healthcare solutions | Corporate Officer/Principal | - |
Training of Olivier Jarry
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
44
1st degree connections
11
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Novartis International AG
Novartis International AG Pharmaceuticals: MajorHealth Technology Offers healthcare solutions | Health Technology |
Precigen, Inc.
 Precigen, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company | Health Technology |
DarioHealth Corp.
 DarioHealth Corp. Medical SpecialtiesHealth Technology Develops medical devices and mobile applications for self-monitoring of blood glucose | Health Technology |
École Centrale Paris
 École Centrale Paris Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bayer Healthcare Pharmaceuticals LLC | |
Trium Global Emba
 Trium Global Emba Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rational Vaccines, Inc.
Rational Vaccines, Inc. BiotechnologyHealth Technology Develops virus vaccines for retraining the immune systems | Health Technology |
OS Therapies, Inc.
 OS Therapies, Inc. BiotechnologyHealth Technology Operates as a clinical stage therapeutic company engages in development and commercialization of treatments for osteosarcoma | Health Technology |
Advantage Therapeutics, Inc.
Advantage Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops immunotherapies treat neurodegenerative conditions | Health Technology |
Libera Bio SL
Libera Bio SL Miscellaneous Commercial ServicesCommercial Services Operates as biopharmaceutical company that develops cancer therapeutics | Commercial Services |
- Stock Market
- Insiders
- Olivier Jarry
